Dr. Mac T. McLaughlin, MD

Dr. McLaughlin practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. McLaughlin's NPI, 1851518138, was assigned on April 19, 2007. Dr. McLaughlin graduated from University of Nebraska College of Medicine in 2006. Dr. McLaughlin holds Nebraska license 26303.

Dr. McLaughlin's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. McLaughlin also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. McLaughlin's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. Dr. McLaughlin is also affiliated with Bellevue Medical Center. The medical group on file is UNMC Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McLaughlin practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. McLaughlin's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. McLaughlin's licenses on file in 2 states: Nebraska and Massachusetts.

CMS data shows 165 Medicare services from Dr. McLaughlin across 5 procedure codes in 2024, for 141 Medicare patients. Medicare paid $14,168 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 141 Medicare patients who saw Dr. McLaughlin in 2024. The largest group is 65 to 74, with 64 patients. 73% of them have high blood pressure, and 59% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McLaughlin's median patient age at 63, with 56% women.

In 2024, Dr. McLaughlin wrote 446 Medicare Part D claims for 54 patients. 83% of them were for generic drugs. CMS names the drug for 344 of them, across 12 drugs with 11 or more claims each, at $477,404 in total drug cost. In 2023, CMS named 402 claims across 14 drugs.

Dr. McLaughlin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McLaughlin as offering telehealth.

Dmand AI links 1 paper to Dr. McLaughlin in 2023.

CMS Open Payments shows 6 general payments to Dr. McLaughlin from 3 drug and device companies from 2017 to 2023. Speaker and faculty fees make up the largest share, 97% of the total. Biogen, Inc. paid the most, $10,086.

Dr. McLaughlin graduated from University of Nebraska College of Medicine in 2006.